Neuberger Berman Group
MIRM icon

Neuberger Berman Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Neuberger Berman Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Buy
139,447
+58,898
+73% +$5.91M 0.01% 762
2026
Q1 		$7.44M Buy
+80,549
New +$7.58M 0.01% 891

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group's MIRM Position: Q2 2026 in Review

Neuberger Berman Group increased its Mirum Pharmaceuticals (MIRM) stake by 73% in Q2 2026, buying an estimated $5.91M and bringing the position to 139,447 shares worth $16.3M. The position accounts for 0.01% of the portfolio, ranked #762.

Neuberger Berman Group first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Neuberger Berman Group held 139,447 shares of Mirum Pharmaceuticals worth $16.3M as of Q2 2026.
  • Neuberger Berman Group bought 58,898 Mirum Pharmaceuticals shares in Q2 2026, an estimated $5.91M.
  • Mirum Pharmaceuticals made up 0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #762 holding.
  • Neuberger Berman Group first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.